KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Total Non-Current Liabilities (2016 - 2023)

Historic Total Non-Current Liabilities for Palvella Therapeutics (PVLA) over the last 11 years, with Q4 2023 value amounting to $10.4 million.

  • Palvella Therapeutics' Total Non-Current Liabilities fell 8458.58% to $10.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $10.4 million, marking a year-over-year decrease of 8458.58%. This contributed to the annual value of $10.4 million for FY2023, which is 8458.58% down from last year.
  • Palvella Therapeutics' Total Non-Current Liabilities amounted to $10.4 million in Q4 2023, which was down 8458.58% from $47.0 million recorded in Q2 2023.
  • Palvella Therapeutics' Total Non-Current Liabilities' 5-year high stood at $110.3 million during Q3 2021, with a 5-year trough of $10.4 million in Q4 2023.
  • For the 5-year period, Palvella Therapeutics' Total Non-Current Liabilities averaged around $81.0 million, with its median value being $86.9 million (2019).
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first soared by 3896.89% in 2021, then crashed by 8458.58% in 2023.
  • Over the past 5 years, Palvella Therapeutics' Total Non-Current Liabilities (Quarter) stood at $89.7 million in 2019, then decreased by 17.57% to $74.0 million in 2020, then surged by 38.97% to $102.8 million in 2021, then tumbled by 34.28% to $67.6 million in 2022, then tumbled by 84.59% to $10.4 million in 2023.
  • Its last three reported values are $10.4 million in Q4 2023, $47.0 million for Q2 2023, and $67.6 million during Q4 2022.